👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Stock Market Today: Dow closes at record high as earnings season continues

Published 10/15/2024, 07:45 PM
Updated 10/16/2024, 04:21 PM
© Reuters
US500
-
C
-
BAC
-
MSFT
-
GS
-
AAPL
-
MS
-
ABT
-
UAL
-
IXIC
-
NVAX
-
ASML
-

Investing.com -- The Dow closed at record highs Wednesday, following a wobble the previous day as chip stocks steadied and Wall Street continued to roll out quarterly earnings.  

At 4:00 p.m. ET (2000 GMT), the Dow Jones Industrial Average rose 337 points, or 0.8% to record close of 43,077.70. While the S&P 500 added 0.5%, and NASDAQ Composite gained 0.3%.

Morgan Stanley continues upbeat earnings from banks  

Morgan Stanley (NYSE:MS) stock rose more than 6% after the lender's profit surpassed estimates on a bumper third quarter for investment banking that had also buoyed rivals.

This rounded off the numbers from the sector, following largely positive earnings from the likes of Goldman Sachs (NYSE:GS), Citigroup (NYSE:C) and Bank of America (NYSE:BAC). 

Beyond the banks, Abbott Laboratories (NYSE:ABT) rose more than 1% after the company slightly lifted its annual profit forecast, after beating Wall Street estimates for quarterly earnings on strong sales of its medical devices including its glucose-monitoring products.

United Airlines (NASDAQ:UAL) stock rose 12% after the carrier reporting third-quarter earnings ahead of expectations and announcing a new $1.5 billion share repurchase program.

Chip stocks steady but tech struggle continues  

Tech stocks were in the red Wednesday as a rebound in chip stocks following an ASML (NASDAQ:ASML)- led rout was offset by weakness in Microsoft (NASDAQ:MSFT) and Apple (NASDAQ:AAPL). 

ASML (AS:ASML) fell more than 5% adding to its losses from a day earlier when the chip equipment maker cut its 2025 sales forecast, triggering concerns about softer AI demand.  

Chipmakers were also rattled by a report suggesting the U.S. government was considering limiting sales of AI-related chips to certain countries - a scenario that heralds weaker sales.

Novavax slumps as FDA pauses combo flu-COVID vaccine trial

Novavax Inc (NASDAQ:NVAX) fell more than 19% after the U.S. Food and Drug Administration paused the company's trial of an experimental COVID-flu vaccine combination.  

(Peter Nurse, Ambar Warrick contributed to this article.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.